地塞米松和瑞德西韦：在新冠疫情的疯狂中寻找方法。 - Suppr

Dexamethasone and remdesivir: finding method in the COVID-19 madness.

作者信息

Vetter Pauline, Kaiser Laurent, Calmy Alexandra, Agoritsas Thomas, Huttner Angela

机构信息

Geneva Centre for Emerging Viral Diseases and Laboratory of Virology, Geneva University Hospitals, 1205 Geneva, Switzerland; Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.

出版信息

Lancet Microbe. 2020 Dec;1(8):e309-e310. doi: 10.1016/S2666-5247(20)30173-7. Epub 2020 Oct 23.

DOI:10.1016/S2666-5247(20)30173-7

PMID:35544181

Abstract

摘要

相似文献

Dexamethasone and remdesivir: finding method in the COVID-19 madness.

Lancet Microbe. 2020 Dec;1(8):e309-e310. doi: 10.1016/S2666-5247(20)30173-7. Epub 2020 Oct 23.

Use of Remdesivir in Myasthenia gravis and COVID-19.

Pharmacotherapy. 2021 Jun;41(6):546-550. doi: 10.1002/phar.2524. Epub 2021 Apr 27.

Experts Discuss COVID-19-Remdesivir, Vaccines, and More.

JAMA. 2020 Aug 25;324(8):730-731. doi: 10.1001/jama.2020.15067.

Real-life use of remdesivir in hospitalized patients with COVID-19.

Rev Esp Quimioter. 2021 Apr;34(2):136-140. doi: 10.37201/req/018.2021. Epub 2021 Mar 6.

Inhaled remdesivir treatment for COVID-19.

Int J Tuberc Lung Dis. 2021 Oct 1;25(10):788-790. doi: 10.5588/ijtld.21.0282.

Remdesivir in The Treatment of COVID-19.

Am J Nurs. 2021 Jan 1;121(1):55. doi: 10.1097/01.NAJ.0000731668.01845.8c.

USA stockpiling of remdesivir: How should the world respond?

J Comp Eff Res. 2020 Dec;9(18):1243-1246. doi: 10.2217/cer-2020-0174. Epub 2020 Dec 4.

COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.

Med Lett Drugs Ther. 2022 Feb 21;64(1644):31-32.

COVID-19 survivors with calcineurin-inhibitors-treated rheumatoid arthritis.

Mod Rheumatol Case Rep. 2022 Jan 7;6(1):10-13. doi: 10.1093/mrcr/rxab023.

Treating COVID-19 Acute Severe Hypoxemic Respiratory Failure: First Case Report Utilizing Dexamethasone, Remdesivir, and Convalescent Plasma in Operation Inherent Resolve.

Med J (Ft Sam Houst Tex). 2021 Jan-Mar(PB 8-21-01/02/03):28-33.

引用本文的文献

COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefits.

PLoS One. 2022 Mar 17;17(3):e0264785. doi: 10.1371/journal.pone.0264785. eCollection 2022.

Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.

Egypt J Intern Med. 2022;34(1):19. doi: 10.1186/s43162-022-00113-z. Epub 2022 Feb 15.

Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines.

Front Cell Infect Microbiol. 2021 Dec 14;11:763687. doi: 10.3389/fcimb.2021.763687. eCollection 2021.

Adverse Cardiovascular Effects of Anti-COVID-19 Drugs.

Front Pharmacol. 2021 Aug 25;12:699949. doi: 10.3389/fphar.2021.699949. eCollection 2021.

A Nationwide Cross-Sectional Online Survey on the Treatment of COVID-19-ARDS: High Variance in Standard of Care in German ICUs.

J Clin Med. 2021 Jul 29;10(15):3363. doi: 10.3390/jcm10153363.

Covasim: An agent-based model of COVID-19 dynamics and interventions.

PLoS Comput Biol. 2021 Jul 26;17(7):e1009149. doi: 10.1371/journal.pcbi.1009149. eCollection 2021 Jul.

Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial.

BMC Infect Dis. 2021 Apr 10;21(1):337. doi: 10.1186/s12879-021-06045-3.

Prediction Models for the Clinical Severity of Patients With COVID-19 in Korea: Retrospective Multicenter Cohort Study.

J Med Internet Res. 2021 Apr 16;23(4):e25852. doi: 10.2196/25852.

MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2.

Noncoding RNA. 2021 Feb 18;7(1):14. doi: 10.3390/ncrna7010014.

COVID-19 drug practices risk antimicrobial resistance evolution.

Lancet Microbe. 2021 Apr;2(4):e135-e136. doi: 10.1016/S2666-5247(21)00039-2. Epub 2021 Feb 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Dexamethasone and remdesivir: finding method in the COVID-19 madness.

作者信息

Vetter Pauline, Kaiser Laurent, Calmy Alexandra, Agoritsas Thomas, Huttner Angela

机构信息

出版信息

Lancet Microbe. 2020 Dec;1(8):e309-e310. doi: 10.1016/S2666-5247(20)30173-7. Epub 2020 Oct 23.

DOI:10.1016/S2666-5247(20)30173-7

PMID:35544181

Abstract

摘要

相似文献

Dexamethasone and remdesivir: finding method in the COVID-19 madness.

Lancet Microbe. 2020 Dec;1(8):e309-e310. doi: 10.1016/S2666-5247(20)30173-7. Epub 2020 Oct 23.

Use of Remdesivir in Myasthenia gravis and COVID-19.

Pharmacotherapy. 2021 Jun;41(6):546-550. doi: 10.1002/phar.2524. Epub 2021 Apr 27.

Experts Discuss COVID-19-Remdesivir, Vaccines, and More.

JAMA. 2020 Aug 25;324(8):730-731. doi: 10.1001/jama.2020.15067.

Real-life use of remdesivir in hospitalized patients with COVID-19.

Rev Esp Quimioter. 2021 Apr;34(2):136-140. doi: 10.37201/req/018.2021. Epub 2021 Mar 6.

Inhaled remdesivir treatment for COVID-19.

Int J Tuberc Lung Dis. 2021 Oct 1;25(10):788-790. doi: 10.5588/ijtld.21.0282.

Remdesivir in The Treatment of COVID-19.

Am J Nurs. 2021 Jan 1;121(1):55. doi: 10.1097/01.NAJ.0000731668.01845.8c.

USA stockpiling of remdesivir: How should the world respond?

J Comp Eff Res. 2020 Dec;9(18):1243-1246. doi: 10.2217/cer-2020-0174. Epub 2020 Dec 4.

COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.

Med Lett Drugs Ther. 2022 Feb 21;64(1644):31-32.

COVID-19 survivors with calcineurin-inhibitors-treated rheumatoid arthritis.

Mod Rheumatol Case Rep. 2022 Jan 7;6(1):10-13. doi: 10.1093/mrcr/rxab023.

Treating COVID-19 Acute Severe Hypoxemic Respiratory Failure: First Case Report Utilizing Dexamethasone, Remdesivir, and Convalescent Plasma in Operation Inherent Resolve.

Med J (Ft Sam Houst Tex). 2021 Jan-Mar(PB 8-21-01/02/03):28-33.

引用本文的文献

COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefits.

PLoS One. 2022 Mar 17;17(3):e0264785. doi: 10.1371/journal.pone.0264785. eCollection 2022.

Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.

Egypt J Intern Med. 2022;34(1):19. doi: 10.1186/s43162-022-00113-z. Epub 2022 Feb 15.

Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines.

Front Cell Infect Microbiol. 2021 Dec 14;11:763687. doi: 10.3389/fcimb.2021.763687. eCollection 2021.

Adverse Cardiovascular Effects of Anti-COVID-19 Drugs.

Front Pharmacol. 2021 Aug 25;12:699949. doi: 10.3389/fphar.2021.699949. eCollection 2021.

A Nationwide Cross-Sectional Online Survey on the Treatment of COVID-19-ARDS: High Variance in Standard of Care in German ICUs.

J Clin Med. 2021 Jul 29;10(15):3363. doi: 10.3390/jcm10153363.

Covasim: An agent-based model of COVID-19 dynamics and interventions.

PLoS Comput Biol. 2021 Jul 26;17(7):e1009149. doi: 10.1371/journal.pcbi.1009149. eCollection 2021 Jul.

Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial.

BMC Infect Dis. 2021 Apr 10;21(1):337. doi: 10.1186/s12879-021-06045-3.

Prediction Models for the Clinical Severity of Patients With COVID-19 in Korea: Retrospective Multicenter Cohort Study.

J Med Internet Res. 2021 Apr 16;23(4):e25852. doi: 10.2196/25852.

MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2.

Noncoding RNA. 2021 Feb 18;7(1):14. doi: 10.3390/ncrna7010014.

COVID-19 drug practices risk antimicrobial resistance evolution.

Lancet Microbe. 2021 Apr;2(4):e135-e136. doi: 10.1016/S2666-5247(21)00039-2. Epub 2021 Feb 24.

Dexamethasone and remdesivir: finding method in the COVID-19 madness.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Dexamethasone and remdesivir: finding method in the COVID-19 madness.

作者信息

机构信息

出版信息

相似文献

引用本文的文献